Vivo Bio Tech Ltd.
BSE: 511509 | Sector: Health care |
NSE: N.A. | ISIN Code: INE380K01017 |
BSE 00:00 | 23 May | 39.15 |
-0.90 (-2.25%) |
OPEN
40.00 |
HIGH
41.00 |
LOW
38.80 |
NSE 05:30 | 01 Jan | Vivo Bio Tech Ltd |
OPEN | 40.00 |
PREVIOUS CLOSE | 40.05 |
VOLUME | 4993 |
52-Week high | 115.10 |
52-Week low | 36.45 |
P/E | 18.29 |
Mkt Cap.(Rs cr) | 58 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Vivo Bio Tech Ltd. (VIVOBIOTECH) - Company Information
Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD AAALAC & IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining d...> More
COMPANY INFORMATION | |||||||
Whole-time Director : | Kalyan Ram Mangipudi | ||||||
Director : | Alangudi Sankaranarayanan | ||||||
Chairman & Independent Directo : | K Sunder | ||||||
Independent Director : | Hariharan Ravindran | ||||||
Whole Time Director & CFO : | Tejomurthula Viswaswara Kaladhar Kuppambhotla | ||||||
Independent Director : | Kunda Kalpana | ||||||
Director : | Karopadi Shivanand Nayak | ||||||
WTD & Additional Director : | K Sri Kalyan | ||||||
AUDITOR : | P C N & Associates | ||||||
IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
Survey #349/A Pregnapur Vlge, ,Gajel,Telangana-502311 | |||||||
Ph : | |||||||
WEBSITE : http://www.vivobio.com | |||||||
E-mail : investors@vivobio.com |
Quick Links for Vivo Bio Tech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices